News Headlines Article

Investors profit from surgeries on patients of mesh implants gone wrong
Modern Healthcare

The tidal wave of lawsuits over pelvic mesh implants seems to have spurred a new business—one that some say profits by preying on patients who’ve sued over the devices, according to a Reuters investigation.

Here’s how it works: Medical funders buy debt—for a fraction of its actual cost—from providers doing corrective surgery on patients with mesh implants. When those patients’ lawsuits over the implants settle, the medical funder places a lien for the full amount of the surgical bill, claiming large amounts of the settlement money, according to Reuters.

Medical lenders have asked for as much as $62,000 for the surgeries and other services. That’s compared with the standard insurance reimbursement rate for mesh removal surgery, about $2,000 to $7,000.